• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.45% Nasdaq Up0.40%

    Aoxing Pharmaceutical Company, Inc. (AXN)

    -NYSE MKT
    0.75 Down 0.04(5.05%) 4:00PM EDT
    ProfileGet Profile for:
    Aoxing Pharmaceutical Company, Inc.
    No.1, Nanhuan Eastern Road
    Xinle County
    Shijiazhuang, 050700
    China - Map
    Phone: 86 311 8519 6888
    Fax: 86 311 8519 6969
    Website: http://www.aoxingpharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:339

    Business Summary 

    Aoxing Pharmaceutical Co., Inc., a specialty pharmaceutical company, engages in research, development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China. The company’s principal products comprise Zhongtongan, a capsule of herbal extraction for the indication of oral and dental pain; and Bismuth Potassium Citrate, an oral solution for the treatment of chronic gastritis and stomachache due to excessive stomach acid. Its products under development include Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone that has completed phase I and phase II clinical trial for the treatment of opioid dependence; and Tilidine/Naloxone, which is in Phase II clinical trials to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Aoxing Pharmaceutical Company, Inc.

    Key Executives 
     PayExercised
    Mr. Zhenjiang Yue , 57
    Chairman and Chief Exec. Officer
    162.00K0.00
    Dr. Zheng Chen Ph.D., CFA, MBA, 50
    Chief Financial Officer
    N/AN/A
    Mr. Guoan Zhang , 46
    Chief Accounting Officer and Sr. VP of Fin.
    N/AN/A
    Ms. Yunlan Tang , 70
    Chief Engineer
    N/AN/A
    Wei Zhang ,
    Corp. Sec.
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders